Leukocyte-mediated tissue injury in ischemic stroke

Current Medicinal Chemistry

Volumn 21, Issue 19, 2014, Pages 2130-2137

  Rodrigues, S F ^a   Granger, D N ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Ischemic stroke; Leukocyte recruitment; Leukocyte derived mediators; Mechanisms of tissue injury

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; ARENARIOSIDE; BIOLOGICAL MARKER; CR 6; CRATAEGUS EXTRACT; ESTRADIOL; FINGOLIMOD; FORSYTHOSIDE B; GHRELIN; GRANZYME B; INTERLEUKIN 17 ANTIBODY; LJ 529; LJP 1586; LXA 4ME; MFG E 8; MOXIFLOXACIN; ONO AE 3 240; PHOSPHATIDYLINOSITOL 3 KINASE; PIOGLITAZONE; PROGESTERONE; REACTIVE OXYGEN METABOLITE; ROSIGLITAZONE; RTL 551; SCR 15 18; TAURINE; TOFACITINIB; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ARTICLE; BRAIN ISCHEMIA; CELL POPULATION; HUMAN; LEUKOCYTE; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; NONHUMAN; PATHOPHYSIOLOGY; TISSUE INJURY; ANIMAL; CELL MOTION; CEREBROVASCULAR ACCIDENT; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; METABOLISM;

ANIMALS; BRAIN ISCHEMIA; CELL MOVEMENT; DISEASE MODELS, ANIMAL; HUMANS; LEUKOCYTES; STROKE;

EID: 84899864374     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867321666131228192119     Document Type: Article

References (99)

1. Sacco, R.L.; Adams, R.; Albers, G.; Alberts, M.J.; Benavente, O.; Furie, K.; Goldstein, L.B.; Gorelick, P.; Halperin, J.; Harbaugh, R.; Johnston, S.C.; Katzan, I.; Kelly-Hayes, M.; Kenton, E.J.; Marks, M.; Schwamm, L.H.; Tomsick, T. American Heart Association. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on. Stroke, 2006, 37(2), 577-617.
2. Kikuchi, K.; Kawahara, K.; Miura, N.; Ito, T.; Morimoto, Y.; Tancharoen, S.; Takeshige, N.; Uchikado, H.; Sakamoto, R.; Miyagi, N.; Kikuchi, C.; Iida, N.; Shiomi, N.; Kuramoto, T.; Hirohata, M.; Maruyama, I.; Morioka, M.; Tanaka, E. Secondary prevention of stroke: Pleiotropic effects of optimal oral pharmacotherapy. Exp. Ther. Med., 2012, 4(1), 3-7.
3. Amarenco, P.; Bogousslavsky, J.; Caplan, L.; Donnan,G.; Hennerici, M. Classification of stroke subtypes. Cerebrovasc. Dis., 2009, 27(5), 493-501.
4. Kis, Z.; Sas, K.; Gyulai, Z.; Treso, B.; Petrovay, F.; Kapusinszky, B.; Csire, M.; Endresz, V.; Burian, K.; Mandi, Y.; Vecsei, L.; Gonczol, E. Chronic infections and genetic factors in the development of ischemic stroke. New Microbiol., 2007, 30(3), 213-220.
5. Xu, Y.; Sharma, D.; Li, G.; Liu, Y. Atrial remodeling: New pathophysiological mechanism of atrial fibrillation. Med. Hypotheses, 2013, 80(1), 53-56.
6. Kolominsky-Rabas, P.; Weber, M.; Gefeller, O.; Neundorfer, B.; Heuschemann, P. Epidemiology of ischemic stroke subtypes according to TOAST criteria. Incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke, 2001, 32(12), 2735-2740.
7. Derdeyn, C. Mechanisms of ischemic stroke secondary to large artery atherosclerotic disease. Neuroimaging Clin. N. Am., 2007, 17(3), 303-311.
8. Bogousslavsky, J.; Cachin, C.; Regli, F.; Despland, P.; Van Melle, G.; Kappenberger, L. Cardiac sources of embolism and cerebral infarction - clinical consequences and vascular concomitants: the Lausanne Stroke Registry. Neurology, 1991, 41(6), 855-859.
9. Ferro, J. Cardioembolic stroke: an update. Lancet Neurol., 2003, 2(3), 177-188.
10. Álvarez-Pérez, F.;Verde, I.; Usón-Martín, M.; Figuerola-Roig, A.; Ballabriga-Planas,J.;Espino-Ibañez, A. Frequency and mechanism of ischemic stroke associated with malignancy: a retrospective series. Eur. Neurol., 2012, 68(4), 209-213.
11. Ihle-Hansen, H.; Thommessen, B.; Wyller, T.; Engedal, K.; Fure, B. Risk factors for and incidence of subtypes of ischemic stroke. Funct. Neurol., 2012, 27(1), 35-40.
12. Sen, S.; Rabinstein, A.; Elkind, M.; Powers, W. Recent developments regarding human immunodeficiency virus infection and stroke. Cerebrovasc. Dis., 2012, 33(3), 209-218.
13. Schulze, J.; Zierath, D.; Tanzi, P.; Cain, K.; Shibata, D.; Dressel, A.; Becker, K. Severe stroke induces long-lasting alterations of high-mobility group box 1. Stroke, 2013, 44(1), 246-248.
14. Ruscher, K.; Inácio, A.; Valind, K.; Rowshan Ravan, A.; Kuric, E.; Wieloch, T. Effects of the sigma-1 receptor agonist 1-(3,4- dimethoxyphenethyl)-4-(3-phenylpropyl)-piperazine dihydrochloride on inflammation after stroke. PLoS One, 2012, 7(9), e45118.
15. Huang, J.; Li, Y.; Tang, Y.; Tang, G.; Yang, G.; Wang, Y. CXCR4 Antagonist AMD3100 Protects Blood-Brain Barrier Integrity and Reduces Inflammatory Response After Focal Ischemia in Mice. Stroke, 2013, 44(1), 190-197.
16. Chen, S.; Martens-Lobenhoffer, J.; Weissenborn, K.; Kielstein, J.; Lichtinghagen, R.; Deb, M.; Li, N.; Tryc, A.; Goldbecker, A.; Dong, Q.; Bode-Böger, S.; Worthmann, H. Association of dimethylarginines and mediators of inflammation after acute ischemic stroke. J. Neuroinflammation, 2012, 9, 251.
17. Yan, J.; Greer, J.; McCombe, P. Prolonged elevation of cytokine levels after human acute ischaemic stroke with evidence of individual variability. J. Neuroimmunol., 2012, 246(1-2), 78-84.
18. Shichita, T.; Ago, T.; Kamouchi, M.; Kitazono, T.; Yoshimura, A.; Ooboshi, H. Novel therapeutic strategies targeting innate immune responses and early inflammation after stroke. J. Neurochem., 2012, 123(suppl 2), 29-38.
19. Gelderblom, M.; Weymar, A.; Bernreuther, C.; Velden, J.; Arunachalam, P.; Steinbach, K.; Orthey, E.; Arumugam, T.; Leypoldt, F.; Simova, O.; Thom, V.; Friese, M.; Prinz, I.; Hölscher, C.; Glatzel, M.; Korn, T.; Gerloff, C.; Tolosa, E.; Magnus, T. Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood, 2012, 120(18), 3793-3802.
20. Benakis, C.; Vaslin, A.; Pasquali, C.; Hirt, L. Neuroprotection by inhibiting the c-Jun N-terminal kinase pathway after cerebral ischemia occurs independently of interleukin-6 and keratinocytederived chemokine (KC/CXCL1) secretion. J. Neuroinflammation, 2012, 9, 76.
21. Shichita, T.; Hasegawa, E.; Kimura, A.; Morita, R.; Sakaguchi, R.; Takada, I.; Sekiya, T.; Ooboshi, H.; Kitazono, T.; Yanagawa, T.; Ishii, T.; Takahashi, H.; Mori, S.; Nishibori, M.; Kuroda, K.; Akira, S.; Miyake, K.; Yoshimura, A. Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat. Med., 2012, 18(6), 911-917.
22. Zhang, Y.; Wei, X.; Liu, L.; Liu, S.; Wang, Z.; Zhang, B.; Fan, B.; Yang, F.; Huang, S.; Jiang, F.; Chen, Y.; Yi, F. TIPE2, a novel regulator of immunity, protects against experimental stroke. J. Biol. Chem., 2012, 287(39), 32546-32555.
23. Copin, J.; da Silva, R.; Fraga-Silva, R.; Capettini, L.; Quintao, S.; Lenglet, S.; Pelli, G.; Galan, K.; Burger, F.; Braunersreuther, V.; Schaller, K.; Deruaz, M.; Proudfoot, A.; Dallegri, F.; Stergiopulos, N.; Santos, R.; Gasche, Y.; Mach, F.; Montecucco, F. Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice. J. Cereb. Blood Flow Metab., 2013, 33(4), 490-498.
24. Dunn, J.; Wu, Y.; Zhao, Z.; Srinivasan, S.; Natah, S. Training the brain to survive stroke. PLoS One, 2012, 7(9), e45108.
25. Cho, K.; Miyoshi, H.; Kuroda, S.; Yasuda, H.; Kamiyama, K.; Nakagawara, J.; Takigami, M.; Kondo, T.; Atsumi, T. The Phenotype of Infiltrating Macrophages Influences Arteriosclerotic Plaque Vulnerability in the Carotid Artery. J. Stroke Cerebrovasc. Dis., 2013, 22(7), 910-918.
26. Culman, J.; Nguyen-Ngoc, M.; Glatz, T.; Gohlke, P.; Herdegen, T.; Zhao, Y. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: A preclinical stroke trial. Exp. Neurol., 2012, 238(2), 243-253.
27. Dietel, B.; Cicha, I.; Kallmünzer, B.; Tauchi, M.; Yilmaz, A.; Daniel, W.; Schwab, S.; Garlichs, C.; Kollmar, R. Suppression of dendritic cell functions contributes to the anti-inflammatory action of granulocyte-colony stimulating factor in experimental stroke. Exp. Neurol., 2012, 237(2), 379-387.
28. Kleikers, P.; Wingler, K.; Hermans, J.; Diebold, I.; Altenhöfer, S.; Radermacher, K.; Janssen, B.; Görlach, A.; Schmidt, H. NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury. J. Mol. Med. (Berl.), 2012, 90(12), 1391-1406.
29. Sanderson, T.; Reynolds, C.; Kumar, R.; Przyklenk, K.; Hüttemann, M. Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation. Mol. Neurobiol., 2013, 47(1), 9-23.
30. Pradillo, J.; Denes, A.; Greenhalgh, A.; Boutin, H.; Drake, C.; McColl, B.; Barton, E.; Proctor, S.; Russell, J.; Rothwell, N.; Allan, S. Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats. J. Cereb. Blood Flow Metab., 2012, 32(9), 1810-1819.
31. Elvington, A.; Atkinson, C.; Zhu, H.; Yu, J.; Takahashi, K.; Stahl, G.; Kindy, M.; Tomlinson, S. The alternative complement pathway propagates inflammation and injury in murine ischemic stroke. J. Immunol., 2012, 189(9), 4640-4647.
32. Abou-Chebl, A. Management of acute ischemic stroke. Curr. Cardiol. Rep., 2013, 15(4), 348.
33. Gursoy-Ozdemir, Y.; Yemisci, M.; Dalkara, T. Microvascular protection is essential for successful neuroprotection in stroke. J. Neurochem., 2012, 123(Suppl 2), 2-11.
34. Gu, L.; Xiong, X.; Zhang, H.; Xu, B.; Steinberg, G.; Zhao, H. Distinctive effects of T cell subsets in neuronal injury induced by cocultured splenocytes in vitro and by in vivo stroke in mice. Stroke, 2012, 43(7), 1941-1946.
35. Hurn, P.; Subramanian, S.; Parker, S.; Afentoulis, M.; Kaler, L.; Vandenbark, A.; Offner, H. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J. Cereb. Blood Flow Metab., 2007, 27(11), 1798-1805.
36. Yilmaz, G.; Arumugam, T.; Stokes, K.; Granger, D. Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation, 2006, 113(17), 2105-2112.
37. Kleinschnitz, C.; Schwab, N.; Kraft, P.; Hagedorn, I.; Dreykluft, A.; Schwarz, T.; Austinat, M.; Nieswandt, B.; Wiendl, H.; Stoll, G. Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood, 2010, 115(18), 3835-3842.
38. Shichita, T.; Sugiyama, Y.; Ooboshi, H.; Sugimori, H.; Nakagawa, R.; Takada, I.; Iwaki, T.; Okada, Y.; Iida, M.; Cua, D.; Iwakura, Y.; Yoshimura, A. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat. Med., 2009, 15(8), 946-950.
39. Lukasik, M.; Dworacki, G.; Michalak, S.; Kufel-Grabowska, J.; Watala, C.; Kozubski, W. Chronic hyper-reactivity of platelets resulting in enhanced monocyte recruitment in patients after ischaemic stroke. Platelets, 2012, 23(2), 132-142.
40. Smedbakken, L.; Jensen, J.; Hallén, J.; Atar, D.; Januzzi, J.; Halvorsen, B.; Aukrust, P.; Ueland, T. Activated leukocyte cell adhesion molecule and prognosis in acute ischemic stroke. Stroke, 2011, 42(9), 2453-2458.
41. Vogelgesang, A.; May, V.; Grunwald, U.; Bakkeboe, M.; Langner, S.; Wallaschofski, H.; Kessler, C.; Bröker, B.; Dressel, A. Functional status of peripheral blood T-cells in ischemic stroke patients. PLoS One, 2010, 5(1), e8718.
42. Tsai, N.; Chang, W.; Shaw, C.; Jan, C.; Huang, C.; Chen, S.; Chuang, Y.; Lee, L.; Lu, C. The value of leukocyte adhesion molecules in patients after ischemic stroke. J. Neurol., 2009, 256(8), 1296-1302.
43. Liesz, A.; Suri-Payer, E.; Veltkamp, C.; Doerr, H.; Sommer, C.; Rivest, S.; Giese, T.; Veltkamp, R. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med., 2009, 15(2), 192-199.
44. Ren, X.; Akiyoshi, K.; Vandenbark, A.; Hurn, P.; Offner, H. CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke. Metab. Brain Dis., 2011, 26(1), 87-90.
45. Gelderblom, M.; Leypoldt, F.; Steinbach, K.; Behrens, D.; Choe, C.; Siler, D.; Arumugam, T.; Orthey, E.; Gerloff, C.; Tolosa, E.; Magnus, T. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke, 2009, 40(5), 1849-1857.
46. Yilmaz, G.; Granger, D. Leukocyte recruitment and ischemic brain injury. Neuromolecular Med., 2010, 12(2), 193-204.
47. Kim, J.; Song, T.; Park, J.; Lee, H.; Nam, C.; Nam, H.; Kim, Y.;Heo, J. Different prognostic value of white blood cell subtypes in patients with acute cerebral infarction. Atherosclerosis, 2012, 222(2), 464-467.
48. Abbas, A.K.; Lichtman, A.H. In: Basic Immunology Updated Edition (Basic Immunology: Functions and Disorders of the Immune System); Philadelphia, Saunders, 2011, pp. 89-113.
49. Becker, K.J.; McCarron, R.M.; Ruetzler, C.; Laban, O.; Sternberg, E.; Flanders, K.C.; Hallenbeck, J.M. Immunologic tolerance to myelin basic protein decreases stroke size aftertransient focal cerebral ischemia. Proc. Natl. Acad. Sci. USA, 1997, 94(20), 10873-10878.
50. Omari, K.; Dorovini-Zis, K. CD40 expressed by human brain endothelial cells regulates CD4+ T cell adhesion to endothelium. J. Neuroimmunol., 2003, 134(1-2), 166-178.
51. Monaco, C.; Andreakos, E.; Young, S.; Feldmann, M.; Paleolog, E. T cell-mediated signaling to vascular endothelium: induction of cytokines, chemokines, and tissue factor. J. Leukoc. Biol., 2002, 71(4), 659-668.
52. Chatzigeorgiou, A.; Lyberi, M.; Chatzilymperis, G.; Nezos, A.; Kamper, E. CD40/CD40L signaling and its implication in health and disease. Biofactors, 2009, 35(6), 474-483.
53. Ishikawa, M.; Vowinkel, T.; Stokes, K.; Arumugam, T.; Yilmaz, G.; Nanda, A.; Granger, D. CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion. Circulation, 2005, 111(13), 1690-1696.
54. Gaiano, N.; Fishell, G. The role of notch in promoting glial and neural stem cell fates. Annu. Rev. Neurosci., 2002, 25, 471-490.
55. Laky, K.; Fowlkes, B. Notch signaling in CD4 and CD8 T cell development. Curr. Opin. Immunol., 2008, 20(2), 197-202.
56. Liu, Z.; Shirakawa, T.; Li, Y.; Soma, A.; Oka, M.; Dotto, G.; Fairman, R.; Velazquez, O.; Herlyn, M. Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol. Cell. Biol., 2003, 23(1), 14-25.
57. Arumugam, T.; Chan, S.; Jo, D.; Yilmaz, G.; Tang, S.; Cheng, A.; Gleichmann, M.; Okun, E.; Dixit, V.; Chigurupati, S.; Mughal, M.; Ouyang, X.; Miele, L.; Magnus, T.; Poosala, S.; Granger, D.; Mattson, M. Gamma secretase-mediated Notch signaling worsens brain damage and functional outcome in ischemic stroke. Nat. Med., 2006, 12(6), 621-623.
58. Terao, S.; Yilmaz, G.; Stokes, K.; Russell, J.; Ishikawa, M.; Kawase, T.; Granger, D. Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia-reperfusion. Stroke, 2008, 39(9), 2560-2570.
59. Buisson, A.; Lesne, S.; Docagne, F.; Ali, C.; Nicole, O.; MacKenzie,E.;Vivien, D. Transforming growth factor-beta and ischemic brain injury.Cell. Mol. Neurobiol., 2003, 23(4-5), 539-550.
60. Ren, X.; Akiyoshi, K.; Dziennis, S.; Vandenbark, A.; Herson, P.; Hurn, P.; Offner, H. Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J. Neurosci., 2011, 31(23), 8556-8563.
61. Konoeda, F.; Shichita, T.; Yoshida, H.; Sugiyama, Y.; Muto, G.; Hasegawa, E.; Morita, R.; Suzuki, N.; Yoshimura, A. Therapeutic effect of IL-12/23 and their signaling pathway blockade on brain ischemia model.Biochem. Biophys. Res. Commun., 2010, 402(3), 500-506.
62. Langrish, C.; Chen, Y.; Blumenschein, W.; Mattson, J.; Basham, B.; Sedgwick, J.; McClanahan, T.; Kastelein, R.; Cua, D. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med., 2005, 201(2), 233-240.
63. Trinchieri, G.; Pflanz, S.; Kastelein, R. The IL-12 Family of heterodimeric cytokines. Immunity, 2003, 19(5), 641-644.
64. Feske, S.; Sorond, F.; Henderson, G.; Seto, M.; Hitomi, A.; Kawasaki, K.; Sasaki, Y.; Asano, T.; Liao, J. Increased leukocyte ROCK activity in patients after acute ischemic stroke. Brain Res., 2009, 1257, 89-93.
65. Funakoshi, Y.; Ichiki, T.; Shimokawa, H.; Egashira, K.; Takeda, K.; Kaibuchi, K.; Takeya, M.; Yoshimura, T.;Takeshita, A. Rhokinase mediates angiotensin II-induced monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells. Hypertension, 2001, 38(1), 100-104.
66. Takeda, K.; Ichiki, T.; Tokunou, T.; Iino, N.; Fujii, S.; Kitabatake, A.; Shimokawa, H.; Takeshita, A. Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression. Arterioscler. Thromb. Vasc. Biol., 2001, 21(5), 868-873.
67. Shin, H.; Salomone, S.; Potts, E.; Lee, S.; Millican, E.; Noma, K.; Huang, P.; Boas, D.; Liao, J.; Moskowitz, M.; Ayata, C. Rhokinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms. J. Cereb. Blood Flow Metab., 2007, 27(5), 998-1009.
68. Brait, V.; Jackman, K.; Walduck, A.; Selemidis, S.; Diep, H.; Mast, A.; Guida, E.; Broughton, B.; Drummond,G.;Sobey, C. Mechanisms contributing to cerebral infarct size after stroke: gender, reperfusion, T lymphocytes, and Nox2-derived superoxide. J. Cereb. Blood Flow Metab., 2010, 30(7), 1306-1317.
69. Chen, H.; Song, Y.; Chan, P. Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion. J. Cereb. Blood Flow Metab., 2009, 29(7), 1262-1272.
70. Saino, O.; Taguchi, A.; Nakagomi, T.; Nakano-Doi, A.; Kashiwamura, S.; Doe, N.; Nakagomi, N.; Soma, T.; Yoshikawa, H.; Stern, D.; Okamura, H.;Matsuyama, T. Immunodeficiency reduces neural stem/progenitor cell apoptosis and enhances neurogenesis in the cerebral cortex after stroke. J. Neurosci. Res., 2010, 88(11), 2385-2397.
71. Chaitanya, G.; Schwaninger, M.; Alexander,J.;Babu, P. Granzymeb is involved in mediating post-ischemic neuronal death during focal cerebral ischemia in rat model. Neuroscience, 2010, 165(4), 1203-1216.
72. Cockayne, D.; Muchamuel, T.; Grimaldi, J.; Muller-Steffner, H.; Randall, T.; Lund, F.; Murray, R.; Schuber, F.; Howard, M. Mice deficient for the ecto-nicotinamide adenine dinucleotide glycohydrolase CD38 exhibit altered humoral immune responses. Blood, 1998, 92(4), 1324-1333.
73. Choe, C.; Lardong, K.; Gelderblom, M.; Ludewig, P.; Leypoldt, F.; Koch-Nolte, F.; Gerloff, C.; Magnus, T. CD38 exacerbates focal cytokine production, postischemic inflammation and brain injury after focal cerebral ischemia. PLoS One, 2011, 6(5), e19046.
74. Jin, R.;Song, Z.; Yu, S.; Piazza, A.; Nanda, A.; Penninger, J.; Granger, D.;Li, G. Phosphatidylinositol-3-kinase gamma plays a central role in blood-brain barrier dysfunction in acute experimental stroke. Stroke ,2011, 42(7), 2033-2044.
75. Peterfalvi, A.; Molnar, T.; Banati, M.; Pusch, G.; Miko, E.; Bogar, L.; Pal, J.; Szereday, L.; Illes, Z. Impaired function of innate T lymphocytes and NK cells in the acute phase of ischemic stroke. Cerebrovasc. Dis., 2009, 28(5), 490-498.
76. Hug, A.; Dalpke, A.; Wieczorek, N.; Giese, T.; Lorenz, A.; Auffarth, G.; Liesz, A.; Veltkamp, R. Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection. Stroke, 2009, 40(10), 3226-3232.
77. Hattori, H.; Suzuki, S.; Okazaki, Y.; Suzuki, N.; Kuwana, M. Intracranial transplantation of monocyte-derived multipotential cells enhances recovery after ischemic stroke in rats. J. Neurosci. Res., 2012, 90(2), 479-488.
78. Ashcroft, G.S.; Lei, K.; Jin, W.;Longenecker, G.;Kulkarni, A.B.; Greenwell-Wild, T.; Hale-Donze, H.;McGrady, G.; Song, X.Y.; Wahl, S.M.Secretory leukocyte protease inhibitor mediates nonredundant functions necessary for normal wound healing. Nat. Med., 2000, 6(10), 1147-1153.
79. Watcharotayangul, J.; Mao, L.; Xu, H.; Vetri, F.; Baughman, V.; Paisansathan, C.; Pelligrino, D. Post-ischemic vascular adhesion protein-1 inhibition provides neuroprotection in a rat temporary middle cerebral artery occlusion model. J. Neurochem., 2012, 123(Suppl 2), 116-124.
80. Herz, J.; Reitmeir, R.; Hagen, S.; Reinboth, B.; Guo, Z.; Zechariah, A.; ElAli, A.; Doeppner, T.; Bacigaluppi, M.; Pluchino, S.; Kilic, U.; Kilic, E.; Hermann, D. Intracerebroventricularly delivered VEGF promotes contralesional corticorubral plasticity after focal cerebral ischemia via mechanisms involving anti-inflammatory actions. Neurobio. Dis., 2012, 45(3), 1077-1085.
81. Li, S.; Xian, J.; He, L.; Luo, X.; Tan, B.; Yang, Y.; Liu, G.; Wang, Z. The protective effect of SCR(15-18) on cerebral ischemiareperfusion injury. Neurol. Res., 2011, 33(8), 866-874.
82. Cheyuo, C.; Jacob, A.; Wu, R.; Zhou, M.; Qi, L.; Dong, W.; Ji, Y.; Chaung, W.; Wang, H.; Nicastro, J.; Coppa, G.; Wang, P. Recombinant human MFG-E8 attenuates cerebral ischemic injury: its role in anti-inflammation and anti-apoptosis. Neuropharmacology, 2012, 62(2), 890-900.
83. Choi, I.; Lee, J.; Ju, C.; Hwang, S.; Cho, G.; Lee, H.; Choi, W.; Jeong, L.; Kim, W. A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats. Am. J. Pathol., 2011, 179(4), 2042-2052.
84. Ikeda-Matsuo, T.; Tanji, H.; Narumiya, S.; Sasaki, Y. Inhibition of prostaglandin E2 EP3 receptors improves stroke injury via antiinflammatory and anti-apoptotic mechanisms. J. Neuroimmunol., 2011, 238(1-2), 34-43.
85. Dziennis, S.; Mader, S.; Akiyoshi, K.; Ren, X.; Ayala, P.; Burrows, G.; Vandenbark, A.; Herson, P.; Hurn, P.; Offner, H. Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice. Metab. Brain Dis., 2011, 26(2), 123-133.
86. Wang, J.; Zhao, Y.; Liu, C.; Jiang, C.; Zhao, C.; Zhu, Z. Progesterone inhibits inflammatory response pathways after permanent middle cerebral artery occlusion in rats. Mol. Med. Rep., 2011, 4(2), 319-324.
87. Dang, J.; Mitkari, B.; Kipp, M.; Beyer, C. Gonadal steroids prevent cell damage and stimulate behavioral recovery after transient middle cerebral artery occlusion in male and female rats. Brain Behav. Immun., 2011, 25(4), 715-726.
88. Sun, M.; Zhao, Y.; Gu, Y.; Xu, C. Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-βB. Amino Acids, 2012, 42(5), 1735-1747.
89. Elango, C.; Devaraj, S. Immunomodulatory effect of Hawthorn extract in an experimental stroke model. J. Neuroinflammation, 2010, 7, 97.
90. Bao, Y.; Kim, E.; Bhosle, S.; Mehta, H.; Cho, S. A role for spleen monocytes in post-ischemic brain inflammation and injury. J. Neuroinflammation, 2010, 7, 92.
91. Chang, L.; Chen, Y.; Li, J.; Liu, Z.; Wang, Z.; Chen, J.; Cao, W.; Xu, Y. Cocaine-and amphetamine-regulated transcript modulates peripheral immunity and protects against brain injury in experimental stroke. Brain Behav. Immun., 2011, 25(2), 260-269.
92. Ziegler, G.; Freyer, D.; Harhausen, D.; Khojasteh, U.; Nietfeld, W.; Trendelenburg, G. Blocking TLR2 in vivo protects against accumulation of inflammatory cells and neuronal injury in experimental stroke. J. Cereb. Blood Flow Metab., 2011, 31(2), 757-766.
93. Cheyuo, C.; Wu, R.; Zhou, M.; Jacob, A.; Coppa, G.; Wang, P. Ghrelin suppresses inflammation and neuronal nitric oxide synthase in focal cerebral ischemia via the vagus nerve. Shock, 2011, 35(3), 258-265.
94. Gamboa, J.; Blankenship, D.; Niemi, J.; Landreth, G.; Karl, M.; Hilow, E.; Sundararajan, S. Extension of the neuroprotective time window for thiazolidinediones in ischemic stroke is dependent on time of reperfusion. Neuroscience, 2010, 170(3), 846-857.
95. Jiang, W.; Tian, J.; Fu, F.; Zhu, H.; Hou, J. Neuroprotective efficacy and therapeutic window of Forsythoside B: in a rat model of cerebral ischemia and reperfusion injury. Eur. J. Pharmacol., 2010, 640(1-3), 75-81.
96. Wu, Y.; Ye, X.; Guo, P.; Xu, S.; Wang, J.; Yuan, S.; Yao, S.; Shang, Y. Neuroprotective effect of lipoxin A4 methyl ester in a rat model of permanent focal cerebral ischemia. J. Mol. Neurosci., 2010, 42(2), 226-234.
97. Pérez-Asensio, F.; de la Rosa, X.; Jiménez-Altayó, F.; Gorina, R.; Martínez, E.; Messeguer, A.; Vila, E.; Chamorro, A.; Planas, A. Antioxidant CR-6 protects against reperfusion injury after a transient episode of focal brain ischemia in rats. J. Cereb. Blood Flow Metab., 2010, 30(3), 638-652.
98. Murikinati, S.; Jüttler, E.; Keinert, T.; Ridder, D.; Muhammad, S.; Waibler, Z.; Ledent, C.; Zimmer, A.; Kalinke, U.; Schwaninger, M. Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment. FASEB J., 2010, 24(3), 788-798.
99. Czech, B.; Pfeilschifter, W.; Mazaheri-Omrani, N.; Strobel, M.; Kahles, T.; Neumann-Haefelin, T.; Rami, A.; Huwiler, A.; Pfeilschifter, J. The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia. Biochem. Biophys. Res. Commun., 2009, 389(2), 251-256.